annual CFO:
-$348.88M+$45.21M(+11.47%)Summary
- As of today (July 27, 2025), NTLA annual cash flow from operations is -$348.88 million, with the most recent change of +$45.21 million (+11.47%) on December 31, 2024.
- During the last 3 years, NTLA annual CFO has fallen by -$123.85 million (-55.04%).
- NTLA annual CFO is now -1066.19% below its all-time high of $36.11 million, reached on December 31, 2016.
Performance
NTLA Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$148.93M-$63.73M(-74.81%)Summary
- As of today (July 27, 2025), NTLA quarterly cash flow from operations is -$148.93 million, with the most recent change of -$63.73 million (-74.81%) on March 31, 2025.
- Over the past year, NTLA quarterly CFO has dropped by -$28.27 million (-23.43%).
- NTLA quarterly CFO is now -320.47% below its all-time high of $67.55 million, reached on June 30, 2016.
Performance
NTLA quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$377.15M-$28.27M(-8.10%)Summary
- As of today (July 27, 2025), NTLA TTM cash flow from operations is -$377.15 million, with the most recent change of -$28.27 million (-8.10%) on March 31, 2025.
- Over the past year, NTLA TTM CFO has increased by +$28.27 million (+6.97%).
- NTLA TTM CFO is now -863.91% below its all-time high of $49.37 million, reached on June 30, 2016.
Performance
NTLA TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
NTLA Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +11.5% | -23.4% | +7.0% |
| 3 y3 years | -55.0% | -86.6% | -49.4% |
| 5 y5 years | -237.9% | -286.4% | -970.3% |
NTLA Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -55.0% | +11.5% | -156.0% | at low | -32.5% | +7.0% |
| 5 y | 5-year | -599.0% | +11.5% | -359.4% | at low | -970.3% | +7.0% |
| alltime | all time | -1066.2% | +11.5% | -320.5% | at low | -863.9% | +7.0% |
NTLA Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$148.93M(+74.8%) | -$377.15M(+8.1%) |
| Dec 2024 | -$348.88M(-11.5%) | -$85.19M(+0.4%) | -$348.88M(-2.2%) |
| Sep 2024 | - | -$84.84M(+45.8%) | -$356.74M(-4.4%) |
| Jun 2024 | - | -$58.19M(-51.8%) | -$373.28M(-7.9%) |
| Mar 2024 | - | -$120.66M(+29.7%) | -$405.42M(+2.9%) |
| Dec 2023 | -$394.09M(+18.2%) | -$93.05M(-8.2%) | -$394.09M(+0.8%) |
| Sep 2023 | - | -$101.38M(+12.2%) | -$390.90M(+6.2%) |
| Jun 2023 | - | -$90.32M(-17.4%) | -$368.05M(+1.4%) |
| Mar 2023 | - | -$109.33M(+21.7%) | -$362.81M(+8.9%) |
| Dec 2022 | -$333.29M(+48.1%) | -$89.87M(+14.4%) | -$333.29M(+11.8%) |
| Sep 2022 | - | -$78.53M(-7.7%) | -$298.07M(+4.7%) |
| Jun 2022 | - | -$85.09M(+6.6%) | -$284.56M(+12.7%) |
| Mar 2022 | - | -$79.80M(+46.0%) | -$252.46M(+12.2%) |
| Dec 2021 | -$225.03M(+350.9%) | -$54.65M(-15.9%) | -$225.03M(+6.8%) |
| Sep 2021 | - | -$65.02M(+22.7%) | -$210.60M(+20.9%) |
| Jun 2021 | - | -$52.98M(+1.2%) | -$174.14M(+173.2%) |
| Mar 2021 | - | -$52.38M(+30.2%) | -$63.74M(+27.7%) |
| Dec 2020 | -$49.91M | -$40.23M(+40.9%) | -$49.91M(+30.2%) |
| Sep 2020 | - | -$28.56M(-149.7%) | -$38.35M(+8.8%) |
| Jun 2020 | - | $57.42M(-249.0%) | -$35.24M(-70.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$38.55M(+34.5%) | -$120.33M(+16.6%) |
| Dec 2019 | -$103.24M(+68.5%) | -$28.66M(+12.6%) | -$103.24M(+24.2%) |
| Sep 2019 | - | -$25.45M(-8.1%) | -$83.12M(+18.5%) |
| Jun 2019 | - | -$27.68M(+29.0%) | -$70.12M(+8.0%) |
| Mar 2019 | - | -$21.45M(+151.3%) | -$64.94M(+6.0%) |
| Dec 2018 | -$61.26M(-6.2%) | -$8.54M(-31.4%) | -$61.26M(-17.2%) |
| Sep 2018 | - | -$12.45M(-44.6%) | -$74.03M(-5.7%) |
| Jun 2018 | - | -$22.50M(+26.6%) | -$78.47M(+9.5%) |
| Mar 2018 | - | -$17.77M(-16.6%) | -$71.65M(+9.8%) |
| Dec 2017 | -$65.28M(-280.8%) | -$21.31M(+26.1%) | -$65.28M(+11.8%) |
| Sep 2017 | - | -$16.89M(+7.8%) | -$58.38M(+18.9%) |
| Jun 2017 | - | -$15.68M(+37.6%) | -$49.10M(-243.8%) |
| Mar 2017 | - | -$11.40M(-20.9%) | $34.13M(-5.5%) |
| Dec 2016 | $36.11M(-2148.2%) | -$14.41M(+89.4%) | $36.11M(-19.8%) |
| Sep 2016 | - | -$7.61M(-111.3%) | $45.03M(-8.8%) |
| Jun 2016 | - | $67.55M(-817.0%) | $49.37M(-408.5%) |
| Mar 2016 | - | -$9.42M(+71.6%) | -$16.01M(+807.9%) |
| Dec 2015 | -$1.76M | -$5.49M(+68.1%) | -$1.76M(-147.3%) |
| Sep 2015 | - | -$3.27M(-250.3%) | $3.73M(-46.7%) |
| Jun 2015 | - | $2.17M(-54.9%) | $7.00M(+45.1%) |
| Mar 2015 | - | $4.82M | $4.82M |
FAQ
- What is Intellia Therapeutics, Inc. annual cash flow from operations?
- What is the all time high annual CFO for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. annual CFO year-on-year change?
- What is Intellia Therapeutics, Inc. quarterly cash flow from operations?
- What is the all time high quarterly CFO for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. quarterly CFO year-on-year change?
- What is Intellia Therapeutics, Inc. TTM cash flow from operations?
- What is the all time high TTM CFO for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. TTM CFO year-on-year change?
What is Intellia Therapeutics, Inc. annual cash flow from operations?
The current annual CFO of NTLA is -$348.88M
What is the all time high annual CFO for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high annual cash flow from operations is $36.11M
What is Intellia Therapeutics, Inc. annual CFO year-on-year change?
Over the past year, NTLA annual cash flow from operations has changed by +$45.21M (+11.47%)
What is Intellia Therapeutics, Inc. quarterly cash flow from operations?
The current quarterly CFO of NTLA is -$148.93M
What is the all time high quarterly CFO for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high quarterly cash flow from operations is $67.55M
What is Intellia Therapeutics, Inc. quarterly CFO year-on-year change?
Over the past year, NTLA quarterly cash flow from operations has changed by -$28.27M (-23.43%)
What is Intellia Therapeutics, Inc. TTM cash flow from operations?
The current TTM CFO of NTLA is -$377.15M
What is the all time high TTM CFO for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high TTM cash flow from operations is $49.37M
What is Intellia Therapeutics, Inc. TTM CFO year-on-year change?
Over the past year, NTLA TTM cash flow from operations has changed by +$28.27M (+6.97%)